Çağatay Taşkıran

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli et al. · Journal of Clinical Oncology · 2021 · 376 citations · Full text

The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells

Aytaç Yüksel, Gamze Bildik, Filiz Senbabaoglu et al. · Human Reproduction · 2015 · 139 citations · Full text

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

Christina Fotopoulou, François Planchamp, Tugce Aytulu et al. · International Journal of Gynecological Cancer · 2021 · 101 citations · Full text

Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance

İsmail Güler, Özdemir Himmetoğlu, Ahmet Berkız Turp et al. · Biological Trace Element Research · 2014 · 64 citations

Insulin Resistance, Metabolic Syndrome, Diabetes +8

The long-term survival of women with surgical stage II endometrioid type endometrial cancer

Ali̇ Ayhan, Çağatay Taşkıran, Çetin Çeli̇k et al. · Gynecologic Oncology · 2004 · 61 citations

Gynecological Surgery, Type Endometrial Cancer, Medicine +9